Sunshine Biopharma Inc.
SBFM | NASDAQ
$0.91
+$0.01 (+1.13%)
At close: Sep 21, 2026, 4:00 PM ET
$0.97
+$0.06 (+6.24%)
Pre-market:
Sep 22, 2026, 4:16 AM ET
TTM Period Ending | Q2 2026 Jun 29, 2026 | Q1 2026 Mar 30, 2026 | Q4 2025 Dec 30, 2025 | Q3 2025 Sep 29, 2025 | Q2 2025 Jun 29, 2025 | Q1 2025 Mar 30, 2025 | Q4 2024 Dec 30, 2024 | Q3 2024 Sep 29, 2024 | Q2 2024 Jun 29, 2024 | Q1 2024 Mar 30, 2024 | Q4 2023 Dec 30, 2023 | Q3 2023 Sep 29, 2023 | Q2 2023 Jun 29, 2023 | Q1 2023 Mar 30, 2023 | Q4 2022 Dec 30, 2022 | Q3 2022 Sep 29, 2022 | Q2 2022 Jun 29, 2022 | Q1 2022 Mar 30, 2022 | Q4 2021 Dec 30, 2021 | Q3 2021 Sep 29, 2021 | Q2 2021 Jun 29, 2021 | Q1 2021 Mar 30, 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | 35.35M | 35.49M | 36.31M | 37.32M | 36.34M | 36.23M | 34.87M | 32.96M | 30.48M | 26.74M | 24.09M | 20.35M | 14.53M | 9.12M | 4.35M | 490.88K | 408.45K | 311.01K | 228.43K | 171.32K | 138.1K | 100.37K |
Cost of Revenue | 24.81M | 23.96M | 24.15M | 25M | 24.23M | 25.19M | 24.2M | 22.81M | 21.21M | 17.87M | 15.75M | 13.09M | 9.19M | 5.66M | 2.65M | 261.6K | 215.32K | 159.16K | 117.83K | 67K | 53.84K | 40.48K |
Gross Profit | 10.53M | 11.53M | 12.16M | 12.32M | 12.11M | 11.05M | 10.67M | 10.14M | 9.27M | 8.87M | 8.34M | 7.26M | 5.34M | 3.46M | 1.7M | 229.28K | 193.12K | 151.86K | 110.6K | 104.32K | 84.26K | 59.88K |
Operating Income | -5.2M | -4.58M | -4.48M | -4.86M | -5.43M | -5.71M | -5.76M | -4.91M | -4.59M | -4.33M | -4.81M | -26.99M | -27.92M | -27.61M | -27M | -3.92M | -2.7M | -2.39M | -2.44M | -2.5M | -2.07M | -1.81M |
Interest Income | 230.06K | 253.96K | 280.9K | 322.74K | 356K | 427.28K | 496K | 584.31K | 683.13K | 742.18K | 811.97K | 736.03K | 789.53K | 732.53K | 518.65K | 406.98K | 146.05K | 5 | 2 | 2 | 2 | n/a |
Pretax Income | -5.56M | -5.98M | -5.95M | -6.51M | -6.47M | -5.33M | -5.37M | -4.11M | -3.74M | -3.72M | -4.11M | -26.36M | -27.21M | -26.93M | -26.51M | -2.57M | -5.15M | -7.49M | -12.44M | -14.19M | -10.85M | -8.87M |
Net Income | -5.83M | -6.04M | -5.98M | -5.99M | -6.31M | -5.03M | -5.13M | -4.23M | -3.68M | -4.09M | -4.51M | -26.77M | -27.57M | -27.21M | -26.74M | -2.57M | -5.15M | -7.49M | -12.44M | -14.19M | -10.85M | -8.87M |
Selling & General & Admin | 19.24M | 19.33M | 19.63M | 15.75M | 16.2M | 15.16M | 14.89M | 12.9M | 11.62M | 11.09M | 10.85M | 14.45M | 13.43M | 11.68M | 9.48M | 3.28M | 2.16M | 1.66M | 1.87M | 1.95M | 1.73M | 1.63M |
Research & Development | -366.56K | -183.55K | n/a | 680.08K | 687.14K | 927.15K | 933.9K | 1.6M | 1.71M | 1.64M | 1.86M | 1.08M | 1.21M | 883.13K | 811.86K | 861.29K | 721.26K | 867.08K | 672.21K | 641.96K | 419.49K | 227.73K |
Other Expenses | -3.14M | -3.04M | -2.99M | 750.15K | 655.52K | 666.98K | 610.53K | 555.43K | 524.12K | 458.98K | 438.88K | 18.72M | 18.63M | 18.5M | 18.41M | 9.37K | 11.76K | 12.67K | 12.74K | 13.1K | 13.44K | 13.74K |
Operating Expenses | 15.73M | 16.11M | 16.64M | 17.18M | 17.55M | 16.75M | 16.43M | 15.06M | 13.85M | 13.2M | 13.15M | 34.25M | 33.26M | 31.07M | 28.7M | 4.15M | 2.89M | 2.54M | 2.55M | 2.61M | 2.16M | 1.87M |
Interest Expense | n/a | n/a | n/a | 8.53K | 8.53K | 8.77K | 57.96K | 79.54K | 118.06K | 121.15K | 113.04K | 109.48K | 70.95K | 67.62K | 39.41K | 49.49K | 96.34K | 291.97K | 328.82K | 397.63K | 372.87K | 201.46K |
Selling & Marketing Expenses | 753.25K | 745.57K | 1.14M | 1.04M | 1.09M | 1.14M | 940.28K | 968.38K | 927.53K | 804.38K | 734.25K | 680.69K | 656.46K | 610.96K | 578.09K | 441.77K | 354.1K | 288.42K | 1.22M | 1.17M | 1.04M | 1.02M |
Cost & Expenses | 40.55M | 40.07M | 40.78M | 42.18M | 41.77M | 41.94M | 40.64M | 37.87M | 35.07M | 31.07M | 28.9M | 47.34M | 42.45M | 36.72M | 31.35M | 4.41M | 3.1M | 2.7M | 2.67M | 2.68M | 2.21M | 1.92M |
Income Tax Expense | 270.94K | 61.77K | 21.61K | -515.5K | -162.85K | -297.37K | -234.86K | 114.15K | -60.12K | 371.25K | 395.17K | 408.2K | 367.25K | 279.57K | 233.3K | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Shares Outstanding (Basic) | 1.37M | 490.6K | 415.71K | 465.17K | 22.48K | 270.3K | 258K | 126.8K | 4.97K | 3.21K | 1.19K | 1.29K | 126.8K | 1.1K | 2.24M | 18.89K | 792 | 527.29K | 358.5K | 254.3K | 239.3K | 219.4K |
Shares Outstanding (Diluted) | 1.37M | 490.6K | 415.71K | 465.17K | 22.48K | 270.3K | 258K | 126.8K | 4.97K | 3.21K | 1.19K | 1.29K | 126.8K | 1.1K | 2.26M | 18.89K | 792 | 527.29K | 358.5K | 254.3K | 239.3K | 219.4K |
EPS (Basic) | -10.15 | -87 | -88.90 | -92.70 | -100.20 | -121.60 | -517.60 | -1.56K | -2.05K | -1.96K | -3.11K | -2.07K | -3.16K | -3.76K | -6.81K | -6.79K | -36.99K | -60.59K | -112.39K | -112.46K | -89.84K | -79.11K |
EPS (Diluted) | -10.15 | -87 | -88.90 | -92.70 | -100.20 | -121.60 | -517.60 | -1.56K | -2.05K | -1.96K | -3.11K | -2.07K | -3.16K | -3.76K | -6.9K | -6.88K | -37.08K | -60.68K | -112.39K | -112.46K | -89.84K | -79.11K |
EBITDA | -5.26M | -5.63M | -5.62M | -6.2M | -6.19M | -5.07M | -5.09M | -3.83M | -3.45M | -3.44M | -3.85M | -26.12M | -27.05M | -26.81M | -26.45M | -2.51M | -5.04M | -7.18M | -12.09M | -13.78M | -10.46M | -8.66M |
EBIT | -5.61M | -5.98M | -5.95M | -6.5M | -6.46M | -5.32M | -5.31M | -4.03M | -3.62M | -3.6M | -4M | -26.25M | -27.14M | -26.86M | -26.47M | -2.52M | -5.05M | -7.2M | -12.11M | -13.79M | -10.47M | -8.67M |
Depreciation & Amortization | 349.58K | 344.14K | 332.07K | 298.9K | 267.37K | 245.72K | 223.54K | 200.48K | 173.05K | 157.06K | 149.15K | 125.77K | 89.36K | 56.76K | 25.16K | 9.37K | 11.76K | 12.67K | 12.74K | 13.12K | 13.44K | 13.42K |
Add to Watchlist
Select watchlists to add or remove SBFM